The effects of indomethacin (IDM) and aspirin (ASA) on ACh (10 M) -stimulated exocytotic events were studied in guinea pig antral mucous cells by using video optical microscopy. IDM or ASA, which inhibits cyclooxygenase (COX), decreased the frequency of AChstimulated exocytotic events by 30% or 60%, respectively. The extent of inhibition induced by ASA (60%) decreased by 30% when IDM or arachidonic acid (AA, the substrate of COX) was added. IDM, unlike ASA, appears to induce the accumulation of AA, which enhances the frequency of ACh-stimulated exocytotic events in ASA-treated cells. ONO-8713 (100 M; an inhibitor of the EP1-EP4 prostaglandin receptors) and N- [2-((p-bromocinnamyl) 20 M; an inhibitor of PKA) also decreased the frequency of ACh-stimulated exocytotic events by 60%. However, the supplementation of PGE2 (1 M) prevented the IDM-induced decrease in the frequency of ACh-stimulated exocytotic events. SC-560 (an inhibitor of COX-1) decreased the frequency of ACh-stimulated exocytotic events by 30%, but NS-398 (an inhibitor of COX-2) did not. Moreover, IDM decreased the frequency of exocytotic events stimulated by ionomycin, suggesting that COX-1 activity is stimulated by an increase in intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i). ACh and ionomycin increased PGE2 release in antral mucosal cells. In conclusion, in ACh-stimulated antral mucous cells, an increase in [Ca 2ϩ ]i activates Ca 2ϩ -regulated exocytotic events and PGE2 release mediated by COX-1. The released PGE2 induces the accumulation of cAMP, which enhances the Ca 2ϩ -regulated exocytosis. The autocrine mechanism mediated by PGE2 maintains the high-level mucin release from antral mucous cells during ACh stimulation. gastric mucin secretion; cyclic adenosine 5Ј-monophosphate; cyclooxygenase-1; indomethacin; aspirin MUCIN EXOCYTOSIS IN guinea pig antral mucous cells is regulated by two mechanisms: Ca 2ϩ -regulated exocytosis and cAMPregulated exocytosis (8, 13, (15) (16) (17) . The Ca 2ϩ -regulated exocytosis is the major mechanism operating in antral mucous cells, because the frequency of exocytosis induced by cAMP accumulation was Ͻ10% of that induced by the increase in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) (8, 13, 16, 17 -regulated exocytosis may play an important role in mucin release from antral mucous cells.
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gastric mucin secretion; cyclic adenosine 5Ј-monophosphate; cyclooxygenase-1; indomethacin; aspirin MUCIN EXOCYTOSIS IN guinea pig antral mucous cells is regulated by two mechanisms: Ca 2ϩ -regulated exocytosis and cAMPregulated exocytosis (8, 13, (15) (16) (17) . The Ca 2ϩ -regulated exocytosis is the major mechanism operating in antral mucous cells, because the frequency of exocytosis induced by cAMP accumulation was Ͻ10% of that induced by the increase in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) (8, 13, 16, 17) . The Ca 2ϩ -regulated exocytosis in pancreatic acinar cells consists of two biochemically distinct steps: ATP-dependent priming and Ca 2ϩ -dependent fusion (19, 32) . In our previous study (13) , cAMP accumulation was shown to enhance the Ca 2ϩ -regulated exocytosis by increasing the number of primed granules and Ca 2ϩ sensitivity of fusion in antral mucous cells. This cAMP modulation of Ca 2ϩ -regulated exocytosis may play an important role in mucin release from antral mucous cells.
Many secretagogues, such as PGE 2 , ␤-adrenergic agonists, gastrin, secretin, and histamine, induce the accumulation of cAMP in the gastric mucosa (7). PGE 2 , which induces the accumulation of cAMP in antral mucous cells via the EP4 prostaglandin receptor (16, 17) , protects the gastric mucosa from lesions. In contrast, the inhibition of PGE 2 production by NSAIDs, such as indomethacin (IDM) or aspirin [acetylsalicylic acid (ASA)], induces gastric lesions. The pathogenic mechanisms inducing these lesions are considered to involve multiple factors, such as a decrease in mucin amount, inhibition of glycoprotein synthesis, and gastric hypermotility (20 -22, 26, 27, 34) ; the decrease in mucin release may also be an important factor inducing gastric lesions, especially during a meal.
On the other hand, cholinergic stimulations were reported to enhance PGE 2 release from the gastric mucosa (5, 7, 21) , and P2Y 2 receptor stimulation was reported to induce PGE 2 release from the rat inner medullary collecting duct (31) . Both cholinergic and purinergic stimulations increase [Ca 2ϩ ] i . PGE 2 is generated from arachidonic acid (AA) mediation via cyclooxygenase (COX), which is a Ca 2ϩ -dependent enzyme (9) . In ACh-stimulated antral mucous cells, an increase in [Ca 2ϩ ] i may also stimulate PGE 2 release. The released PGE 2 , which induces cAMP accumulation, may enhance Ca 2ϩ -regulated exocytosis in antral mucous cells (15) . Therefore, the inhibition of PGE 2 synthesis may decrease the frequency of ACh-stimulated exocytotic events. NSAIDs, which inhibit COX, are a tool for inhibiting PGE 2 synthesis. The goal of the present study is to confirm whether released PGE 2 enhances Ca 2ϩ -regulated exocytotic events in ACh-stimulated guinea pig antral mucous cells.
MATERIALS AND METHODS
Solutions and chemicals. Solution I contained (in mM): 121 NaCl, 4.5 KCl, 25 NaHCO 3, 1 MgCl2, 1.5 CaCl2, 5 Na-HEPES, 5 H-HEPES, and 5 glucose. To prepare a Ca 2ϩ -free solution, CaCl2 was excluded from solution I and 1 mM EGTA was added. The pHs of the solutions were all adjusted to 7.4 by adding HCl (1 M). The solutions were gassed with 95% O 2-5% CO2 at 37°C. N- [2-((p-bromocin- namyl)amino)ethyl]-5-isoquinolinesulfonamide, HCl (H-89), ionomycin, SC-560, and NS-398 were purchased from Calbiochem-Novabiochem (La Jolla, CA), ACh was from Daiichi Pharmaceuticals (Osaka, Japan), and PGE 2, IBMX, IDM, ASA, collagenase (for cell dispersion; 180 -220 U/mg), and BSA were from Wako Pure Chemical Industries (Osaka, Japan). ONO-8713 was a generous gift from ONO Pharmaceutical (Osaka, Japan). All reagents were dissolved in DMSO and were prepared to their final concentrations immediately before the experiments. The concentration of DMSO never exceeded 0.1%, and, at this concentration, DMSO does not have any effect on the exocytotic events in antral mucous cells.
Cell preparations. Hartley-strain male guinea pigs weighing ϳ250 g were purchased from Shimizu Experimental Animals (Kyoto, Japan) and were maintained on standard pellet food and water. The guinea pigs were anesthetized by inhalation of ether, after which they were killed by cervical dislocation. The experiments were approved by the Animal Research Committee of Osaka Medical College, and the animals were cared for according to the guidelines of this committee. The procedures for cell preparation have been previously described in detail (8, 15, 16, 25) . Briefly, the antrum was excised and the mucosal layer was stripped from the muscle layer in cooled saline (4°C) by using glass slides. The stripped antral mucosa was minced and then incubated in solution I containing 0.1% collagenase and 2% BSA for 10 min at 37°C. The digested mucosa was then filtered through a nylon mesh with a pore size of 150-m squares and washed three times. The cells were resuspended in solution I containing 2% BSA (4°C). The suspension was stored at 4°C and used in the experiments within 3 h.
Observation of exocytosis. Isolated antral mucous cells were mounted on a coverslip precoated with neutralized Cell-Tak (Becton Dickinson Labware, Bedford, MA) for the firm attachment of cells. The coverslip with cells was set in a perfusion chamber that was mounted on the stage of a differential interference contrast microscope (BX50Wi; Olympus, Tokyo, Japan) connected to a videoenhanced contrast system (model ARGUS-10; Hamamatsu Photonics, Hamamatsu, Japan) (1, 8, 10, (13) (14) (15) (16) (17) . Images were recorded continuously with a video recorder. The experiments were performed at 37°C. The volume of the perfusion chamber was ϳ20 l, and the rate of perfusion was 200 l/min. Exocytotic events, which were detected as rapid changes in the light intensity of granules (1, 3, 10, 11, 13, 14, 16, 17) , were counted in five to six cells every 30 s and were normalized to the cell number (events per cell per 30 s). The frequencies of exocytotic events in three to seven experiments were expressed as means Ϯ SE. Our previous report showed that ACh (10 M) increased the frequency of exocytotic events transiently (8, 13) ; therefore, the initial peak frequency that was observed within 2 min from the start of stimulation (events per cell per 30 s) was used for comparison.
[Ca 2ϩ ]i measurements. The isolated antral mucous cells were incubated in solution I containing 2% BSA and 2.5 M fura-2 AM (Dojindo, Kumamoto, Japan) for 25 min at room temperature (22-24°C). They were then washed with solution I containing 2% BSA three times. Fura-2-loaded cells were resuspended and stored in the solution I-containing 2% BSA at 4°C and then mounted on a coverslip precoated with neutralized Cell-Tak. The coverslip with cells was set in a perfusion chamber, which was then mounted on the stage of an inverted microscope (IX70; Olympus, Tokyo, Japan) connected to an image-analysis system (ARGUS/HiSCA; Hamamatsu Photonics, Hamamatsu, Japan) (8, 13, 14, 16, 33) . All experiments were performed at 37°C. The volume of the perfusion chamber was ϳ80 l, and the rate of perfusion was 500 l/min. Fura-2 was excited at 340 nm and 380 nm, and emission was measured at 510 nm. Fluorescence ratio (F340/F380) was calculated and stored in the image-analysis system. The calibration curve was obtained from F340/F380 of the cell-free Ca 2ϩ calibration solutions containing 10 M fura-2. Solution II contained (in mM) 130 KCl, 20 NaCl, 2 EGTA, and 10 HEPES. To prepare the cell-free Ca 2ϩ -calibration solutions, an appropriate amount of CaCl 2 (0.2-2 mM), calculated by using a computer program, was added to solution II. The pH was adjusted to 7.05 by adding KOH (1 M). The dissociation constant of Ca 2ϩ and EGTA used was 214 nM (37°C, pH 7.05) (12) . One experiment was performed using five to six coverslips, and F340/F380s of three cells on two to three coverslips were expressed as means Ϯ SE.
Measurement of cAMP. The stripped antral mucosa was incubated for 5 min at 37°C in the control solution (10 ml) aerated with a gas mixture (95% O 2-5% CO2), to which ACh (10 M),
, or IBMX (1 mM) was added. In the control experiment, DMSO (10 l) was added to the control solution. After a 5-min incubation, the antral mucosa was immediately frozen in liquid nitrogen and lyophilized at Ϫ80°C for 24 -48 h. After the lyophilized, antral mucosa was weighed, its cAMP content was measured by using a cAMP EIA kit (Amersham International, Little Chalfont, England). The cAMP contents were expressed as moles per milligram of dry weight (14, 16) .
Measurement of PGE 2. The stripped antral mucosa was weighed and then stored in the control solution at 4°C for 30 min before the start of experiments. After the 2-min warmup period, the stripped antral mucosa was incubated in the control solution (10 ml) and aerated with gas mixture (95% O 2-5% CO2) for 10 min before the addition of ACh (10 M), ionomycin (10 M), ASA (10 M), or IDM (10 M) and was then incubated for a further 10 min. In the control experiments, DMSO (10 l) was added instead of ACh or ionomycin. When the inhibitors (ASA and IDM) were used with ACh or ionomycin, the antral mucosa, after the 2-min warmup period, was incubated with the inhibitors for 10 min before the stimulation with ACh or ionomycin. The incubation solution of 500 l was transferred to a microtube immediately before and 10 min after the stimulation. The microtube with sample was immediately cooled on ice and stored at Ϫ30°C until the PGE2 contents assay. PGE2 contents were measured by using a PGE2 EIA kit (Cayman Chemical, Ann Arbor, MI) and were expressed as micrograms per gram of wet weight tissue. The released PGE2 for 10 min was calculated from the difference between values before and 10 min after the stimulation.
The statistical significance of the difference between mean values was assessed by using ANOVA as appropriate. Differences were considered significant at P Ͻ 0.05.
RESULTS
In the present study, the concentration of ACh used was 10 M. ACh (10 M) induced submaximal responses in exocytotic events and increased the frequency of exocytotic events transiently in antral mucous cells (8, 13) . In the control experiments, the frequencies of ACh-stimulated exocytotic events 1 min and 4 min after ACh stimulation were 48.6 Ϯ 1.2 events⅐cell Ϫ1 ⅐30 s Ϫ1 (n ϭ 5) and 5.0 Ϯ 1.2 events⅐cell Ϫ1 ⅐ 30 s Ϫ1 , respectively (Fig. 1A) . Effects of NSAIDs. The dose effects of IDM on the frequency of ACh-stimulated exocytotic events were examined. The cells were treated with IDM for 10 min before ACh stimulation. In unstimulated antral mucous cells, low concentrations (0.1-1 M) of IDM did not induce any exocytotic events. However, high concentrations (10 or 100 M) of IDM slightly increased the frequency of exocytotic events (1-3 events⅐cell Ϫ1 ⅐30 s Ϫ1 ) in some cells 5-8 min after IDM addition (10/25 experiments). The subsequent stimulation with ACh increased the frequency of exocytotic events. A low concentration of IDM (1 M) had no effect on the frequency of ACh-stimulated exocytotic events (Fig. 1A) . However, IDM (10 M) decreased the initial peak frequency of ACh-stimulated exocytotic events by ϳ30% (initial peak frequency ϭ 31.6 Ϯ 4.2 events⅐cell Ϫ1 ⅐30 s Ϫ1 ; n ϭ 5; Fig. 1B ). Similar results were also obtained by using 100 M IDM (Fig. 1C) . The dose effects of IDM on the initial peak frequencies are summarized in Fig. 1D . The initial peak frequencies were significantly smaller in the presence of 10 -100 M IDM than in the control experiments (P Ͻ 0.05).
The effects of ASA were also examined (Fig. 2) . ASA (0.01-100 M), unlike IDM (10 -100 M), did not induce any exocytotic events in unstimulated antral mucous cells. Pretreatment with ASA for 10 min suppressed ACh-stimulated exocytotic events in a dose-dependent manner. ASA (10 M) decreased the initial peak frequency by ϳ60%. The initial peak frequency of ACh-stimulated exocytotic events was 19.9 Ϯ 2.9 events⅐ cell Ϫ1 ⅐30 s Ϫ1 (n ϭ 5; Fig. 2A ). The dose effects of ASA on ACh-stimulated exocytotic events are summarized in Fig. 2B . The initial peak frequencies were significantly smaller in the presence of 1-100 M ASA than those in the control experiments (P Ͻ 0.05).
ASA (10 M) decreased the frequencies of ACh-stimulated exocytotic events to a greater extent than IDM (10 M) (P Ͻ 0.05). ASA and IDM differ in their pharmacological actions, such as binding site and binding reversibility, although they both inhibit PGH synthesis. COX-1 and -2 are capable of synthesizing (15R)-15-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid (15R-HETE) in addition to PGH. ASA, which induces acetylation of COX-1 and -2, inhibits PGH synthesis but not 15R-HETE synthesis (4, 18, 24) . However, IDM inhibits the synthesis of both 15R-HETE and PGH (4). These reports suggest that IDM may induce the accumulation of AA, which is a substrate of COX. The accumulation of AA may modulate Ca 2ϩ -regulated exocytotic events, because AA is already known to mobilize Ca 2ϩ from the intracellular stores (29) . We examined the effects of IDM and AA on ASA-treated antral mucous cells. In Fig. 3A , cells were pretreated with both IDM (100 M) and ASA (10 M) for 10 min and then stimulated with ACh. The addition of IDM enhanced the initial peak frequency of ACh-stimulated exocytotic events in ASAtreated cells (34.6 Ϯ 2.5 events⅐cell Ϫ1 ⅐30 s
Ϫ1
; n ϭ 4). In Fig.  3B , cells were pretreated with both AA (20 M) and ASA (10 M) for 10 min and then stimulated with ACh. The addition of AA enhanced the initial peak frequency of ACh-stimulated exocytotic events in ASA-treated cells (34.3 Ϯ 3.0 events⅐cell Ϫ1 ⅐30 s Ϫ1 ; n ϭ 4). Thus IDM is suggested to induce accumulation of AA, which appears to enhance the frequency of ACh-stimulated exocytotic events.
Effects of PKA inhibitor. IDM or ASA inhibits PGE 2 synthesis in many cell types (7, 18, 31) . Our previous reports (16, 17) showed that PGE 2 induces accumulation of cAMP mediated by the EP4 receptor in antral mucous cells. We then examined the effects of a PKA inhibitor (H-89; 20 M). Cells were pretreated with H-89 (20 M) for 5 min. H-89 (20 M) did not induce any increase in the frequency of exocytotic events in unstimulated cells. The subsequent ACh stimulation increased the frequency of exocytotic events; however, the initial peak frequency of ACh-evoked exocytotic events de- creased by ϳ60% compared with that of the control experiments (Fig. 4A) . The initial peak frequency of ACh-stimulated exocytotic events was 20.7 Ϯ 1.9 events⅐cell Ϫ1 ⅐30 s Ϫ1 (n ϭ 4). When cells were pretreated with both ASA (10 M) and H-89 (20 M) for 5 min, ACh-stimulated exocytotic responses were inhibited similarly (the initial peak frequency ϭ 19.1 Ϯ 1.3 events⅐cell Ϫ1 ⅐30 s
; n ϭ 6). Cells were also pretreated with both IDM (10 M) and H-89 (20 M) for 5 min and subsequently stimulated with ACh. IDM decreased the initial peak frequency of ACh-evoked exocytotic events by ϳ30% in H-89-treated cells (Fig. 4B) . The initial peak frequency of ACh-stimulated exocytotic events was 34.9 Ϯ 3.7 (n ϭ 4), which was similar to that observed in cells treated with IDM alone. Thus IDM, unlike ASA, still enhanced the initial peak frequency of ACh-stimulated exocytotic events in H-89-treated cells.
Effects of PGE 2 . The effects of PGE 2 on ACh-stimulated exocytotic events were examined in IDM-treated antral mucous cells. The antral mucous cells were pretreated with 10 M IDM for 5 min and then stimulated with PGE 2 (1 M) and ACh. Stimulation with PGE 2 increased the initial peak frequency of ACh-stimulated exocytotic events by 15% even in the presence of 10 M IDM (Fig. 5) Cells were treated with ONO-8713 (100 M) for 5 min and then stimulated with ACh. ONO-8713 (100 M) alone did not increase the frequency of exocytotic events. The subsequent stimulation with ACh increased the frequency of exocytotic events. The initial peak frequency was 21.3 Ϯ 1.0 events⅐cell Ϫ1 ⅐30 s Ϫ1 (n ϭ 4). Thus ONO-8713 (100 M) decreased the frequency of ACh-stimulated exocytotic events by ϳ60% (Fig. 6A) .
The effects of ONO-8713 (100 M) on PGE 2 -stimulated exocytotic events were examined. Cells were pretreated with ONO-8713 (100 M) for 5 min. The subsequent addition of PGE 2 (1 M) increased the frequency of exocytotic events only transiently, although PGE 2 (1 M) sustained the frequency of exocytotic events without the pretreatment with ONO-8713 (Fig. 6B) . Thus ONO-8713 (100 M) inhibited EP1 and EP4 receptor subtypes in antral mucous cells.
Effects of IDM on ionomycin-stimulated exocytotic events.
Antral mucous cells were perfused with the Ca 2ϩ -free solution containing 1 M ionomycin. The addition of 1 M ionomycin induced a small transient increase in the frequency of exocytotic events during perfusion with the Ca 2ϩ -free solution. The perfusion solution was suddenly switched to the Ca 2ϩ -containing solution containing 1 M ionomycin (reintroduction of Ca 2ϩ ). The reintroduction of Ca 2ϩ increased the frequency of the exocytotic events transiently, similar to ACh (Fig. 7) . The initial peak frequency of the exocytotic events following the reintroduction of Ca 2ϩ was 59.5 Ϯ 3.4 events⅐cell Ϫ1 ⅐30 s
Ϫ1
(n ϭ 4). Similar experiments were performed in the presence of 10 M IDM. The cells were perfused with the Ca 2ϩ -free solution containing 10 M IDM for 5 min before ionomycin addition. Ionomycin (1 M) did not induce any increase in the frequency of exocytotic events. The reintroduction of Ca 2ϩ increased the frequency of exocytotic events; however, the initial peak frequency decreased by ϳ30%. The initial peak frequency of exocytotic events following the reintroduction of Ca 2ϩ was 42.8 Ϯ 3.9 events⅐cell Ϫ1 ⅐30 s Ϫ1 (n ϭ 4). Thus IDM decreased the frequency of exocytotic events stimulated by ionomycin. These findings suggest that COX is stimulated by an increase in [Ca 2ϩ ] i . 
Effects of inhibitors of COX-1 and COX-2.
Antral mucous cells were pretreated with 80 nM SC-560 (a specifically selective COX-1 inhibitor) and NS-398 (a specifically selective COX-2 inhibitor) for 2 min before ACh stimulation (Fig. 8) . SC-560 (80 nM) induced small increases in the frequency of exocytotic events, similar to IDM, when cells were perfused with SC-560-containing solution for 5-7 min (data not shown). The subsequent ACh stimulation increased the frequency of exocytotic events transiently. However, the initial peak frequency decreased by ϳ30% (33.6 Ϯ 2.5 events⅐cell Ϫ1 ⅐30 s
Ϫ1
; n ϭ 5), compared with that in the control experiments (Fig.  8A) . Similar experiments were performed using NS-398 (20 M). NS-398 (20 M) had no effects on unstimulated cells and ACh-stimulated cells (Fig. 8B) . The initial peak frequency of ACh-stimulated exocytotic events was 45.3 Ϯ 1.6 events⅐cell Ϫ1 ⅐30 s Ϫ1 (n ϭ 4) in the presence of NS-398. These findings suggest that COX-1 generates PGE 2 from AA in guinea pig antral mucous cells.
[ ] i were examined in both IDM-treated and non-IDM-treated antral mucous cells. Stimulation with ACh caused the fura-2 ratio (F340/F380) to increase rapidly and to be sustained in non-IDM-treated cells (Fig. 9A) . Similar increases in F340/F380 were induced by ACh in IDM-treated cells (Fig 9B) . Thus IDM, at least, did not decrease the [Ca 2ϩ ] i during ACh stimulation. cAMP content. The cAMP content was measured in the stripped antral mucosa, which was incubated for 5 min in the control or test solutions. The content of cAMP in the antral mucosa in the control solution was 3.8 Ϯ 0.3 pmol/mg (n ϭ 6). The results summarized in Table 1 show that cAMP content increased approximately twofold in cells stimulated with 10 M ACh, 1 M ionomycin, or 1 M PGE 2 compared with those incubated with the control solution. However, in IDMtreated cells, ACh and ionomycin did not increase cAMP content. The increases in cAMP content evoked by 1 mM IBMX were ϳ15-fold greater than those evoked by 1 M PGE 2 .
PGE 2 release. The PGE 2 released from the stripped antral mucosa for 10 min was measured (Fig. 10) . The amount of PGE 2 released for 10 min was 0.23 Ϯ 0.03 g/g mucosa (n ϭ 3) in the control experiment. Addition of ASA (10 M) or IDM (10 M) decreased the spontaneous PGE 2 release by 30 -50%. Stimulation with ACh (10 M) or ionomycin (10 M) increased PGE 2 release by 70 -80%. IDM or ASA eliminated the increases in PGE 2 release induced by ACh or ionomycin in the antral mucosa. The values with agonists and inhibitors were significantly different from that of the control experiment (P Ͻ 0.05).
DISCUSSION
In antral mucous cells, ACh increased [Ca 2ϩ ] i , which activates Cl Ϫ and HCO 3 Ϫ secretion, cell shrinkage, and mucin exocytosis (8, 13, 16, 25) . The present study, however, demonstrated that a PKA inhibitor (H-89) decreases the frequency of ACh-stimulated exocytotic events and that ACh increases the cAMP content in the antral mucosa. These suggest that ACh also stimulates cAMP accumulation in addition to [Ca 2ϩ ] i increase in antral mucous cells. In our previous report, cAMP accumulation was shown to enhance the frequency of Ca 2ϩ -regulated exocytotic events by modulating priming and fusion steps, although the frequency of cAMP-regulated exocytotic events is Ͻ10% of that of Ca 2ϩ -regulated exocytotic events (8, (15) (16) (17) . These observations indicate that cAMP accumulation induced by ACh stimulation enhances the frequency of Ca 2ϩ -regulated exocytotic events in antral mucous cells. increased the frequency of exocytotic events similar to ACh (10 M; dotted line). In IDM-treated cells, the reintroduction of Ca 2ϩ increased the frequency of exocytotic events; however, the initial peak frequency decreased by ϳ30%. *P Ͻ 0.05 vs. non-IDM treated cells. Fig. 8 . Effects of SC-560 (a COX-1 inhibitor) and NS-398 (a COX-2 inhibitor) on ACh-stimulated exocytotic events. A: SC-560 (80 nM) decreased the initial peak frequency of ACh-stimulated exocytotic events by ϳ30%. *P Ͻ 0.05 vs. control. B: NS-398 (20 M) did not decrease the initial peak frequency of ACh-stimulated exocytotic events.
In the present study, the frequency of ACh-stimulated exocytotic events was decreased by the inhibition of COX (IDM and ASA) and prostanoid EP receptors (100 M ONO-8713). Cholinergic stimulation was reported to increase PGE 2 synthesis in the gastric mucosa (33) . The PGE 2 measurements exhibited that ACh stimulates PGE 2 release mediated via an [Ca 2ϩ ] i increase in antral mucosa. PGE 2 was reported to stimulate cAMP accumulation mediated by the EP4 receptor in antral mucous cells (16, 17) . Moreover, IDM inhibits an increase in cAMP content during ACh stimulation, as shown in the present study. Thus cAMP accumulation is induced by PGE 2 in AChstimulated antral mucous cells.
The NSAID experiments showed that PGE 2 is generated by ASA-and IDM-blockable COX. The IDM-induced suppression of ACh-stimulated exocytotic events was prevented by supplementing PGE 2 (1 M) . The present study demonstrated that IDM decreased the frequency of exocytotic events stimulated by ionomycin; moreover, ionomycin increased cAMP content in antral mucosal cells, which was inhibited by IDM. IDM or ASA inhibited the increases in PGE 2 On the other hand, IDM decreased the frequency of AChstimulated exocytotic events. However, the extent of inhibition induced by IDM was less than that induced by ASA or H-89 (a PKA inhibitor). As described in RESULTS, COX-1 and -2 generate 15R-HETE in addition to PGH. IDM inhibits the synthesis of both (4, 18, 24) . ASA results in the synthesis of 15R-HETE, although it inhibits PGH synthesis (4, 18 24) . This suggests that IDM, unlike ASA, may induce the accumulation of AA (the substrate of COX). We examined the effects of IDM or AA on ASA-treated cells. The results showed that the addition of AA or IDM increased the initial peak frequency of ACh-stimulated exocytotic events in ASA-treated cells in a way similar to that observed in IDM-treated cells. Moreover, IDM increased the frequency of ACh-stimulated exocytotic events in H-89-treated cells. Thus AA increases the frequency of exocytotic events independently of cAMP. AA was reported to be a second messenger for mobilizing intracellular Ca 2ϩ (30) . AA accumulation may modulate Ca 2ϩ mobilization in IDM-treated antral mucous cells.
It is known that two subtypes of COX (COX-1 and COX-2) exist in gastric mucosa. In antral mucous cells, the COX-1 inhibitor (SC-560) decreased the frequency of ACh-stimulated exocytotic events but the COX-2 inhibitor (NS-398) did not. The extent of inhibition induced by SC-560 was similar to that induced by IDM. This suggests that COX-1 regulates PGE 2 synthesis in antral mucous cells. The acetylated COX-1 by ASA was reported to synthesize 15R-HETE, similar to nonacetylated COX-1. The acetylation of COX-2 by ASA, however, was reported to enhance 15R-HETE synthesis by five-or sixfold (4, 18) . If the conversion from AA to 15R-HETE is enhanced by the acetylated COX-2 in ASA-treated antral mucous cells, inhibition of COX-1 (SC-560) is unlikely to increase the ACh-stimulated initial peak frequency, and inhibition of COX-2 (NS-389) is likely to increase it in a way similar to that observed in IDM-treated cells. However, in ASA-treated cells, SC-560 increased the initial peak frequency in a way similar to that observed in IDM-treated cells, and NS-389 did not (S. Fujiwara, unpublished observation). This indicates that the COX-1 synthesizes PGE 2 in antral mucous cells and that the contribution of COX-2 is negligibly small in antral mucous cells. Values are pmol/mg Ϯ SE; n ϭ number of cells. *P Ͻ 0.05 vs. control.
It is known that 15R-HETE is converted to lipoxin A4, which is known to be an inhibitor of acute inflammation (4). Lipoxin A4 synthesized may affect the exocytotic events in antral mucous cells, especially in the presence of ASA. At present, the effects of 15R-HETE or lipoxin A4 on antral mucous cells are unclear. Further studies will be needed.
NSAIDs induce gastric mucosal lesions. The pathogenic mechanisms inducing lesions are considered to involve multiple factors, such as a decrease in the level of endogenous PGs, neutrophil activation, hypermotility, microcirculation dysfunctions, oxygen free radicals, and luminal acid, which closely interact with each other. However, the lesions induced by NSAIDs are prevented by supplementing PGE 2 . PGE 2 was reported to increase mucosal gel layer thickness and mucosal glycoprotein contents in the stomach (2, 20 -22) . Thus one of the causes of NSAID-induced gastric lesions is considered to be the decrease in mucin synthesis (27) . The present study suggests that NSAIDs decrease mucin release from antral mucous cells during maximum stimulations such as having a meal. Thus NSAIDs inhibit not only mucin synthesis but also mucin secretion. In some patients, IDM or ASA is administered continuously, and ASA irreversibly inhibits COX. In these patients, the decrease in mucin release may cause serious problems in digestion or mucosal protection from acid-peptic injury when they are having a meal. Since peptic ulcers occur near the junction between the gastric fundus and the antrum or in the duodenal bulb, supplementation with PGE 2 may prevent the development of antral and duodenal lesions by increasing mucin release.
In unstimulated antral mucous cells, no exocytotic events occurred. Our previous reports showed that PGE 2 (1 M) induced a small increase in the frequency of exocytotic events (1-2 events⅐cell Ϫ1 ⅐30 s Ϫ1 ) (16, 17) . The present study demonstrated that PGE 2 release occurs continuously in unstimulated antral mucosal cells and that the amount of PGE 2 released over 10 min is ϳ0.6 mol/kg tissue. The half-life of PGE 2 is known to be rapid (ϳ30 s in the circulatory system) (6) . If PGE 2 is assumed to be replaced with new PGE 2 within 1 min and extracellular fluid volume is assumed to be 30%, the PGE 2 concentration in the antral mucosa is estimated to be 0.1 M. In our previous report, PGE 2 (0.1 M) activated the exocytotic events in unstimulated antral mucous cells (1 events⅐cell Ϫ1 ⅐30 s Ϫ1 ) (16, 17) . The PGE 2 release in unstimulated antral mucosa appears to maintain the resting mucin release. In our experimental system, however, PGE 2 released from antral mucous cells is immediately diluted by a high perfusion rate, which may not activate exocytotic events.
On the other hand, PGE 2 release in ACh (10 M) -stimulated mucosa was twofold greater than that in unstimulated mucosa. The concentration of PGE 2 also appears to increase to 0.2 M. A small increase in cAMP, which does not activate exocytotic events, still enhances Ca 2ϩ -regulated exocytotic events in antral mucous cells, as shown in our previous report (15) . In our experimental system, the concentration of PGE 2 during ACh stimulation, especially near the cell surface, appears to increase sufficiently to enhance Ca 2ϩ -regulated exocytotic events in antral mucous cells. Therefore, when the gastric branches of the vagus are active, ACh released from the gastric branches stimulates PGE 2 synthesis and release mediated via [Ca 2ϩ ] i increases in antral mucous cells. The PGE 2 release stimulated by ACh appears to maintain mucin release in large amounts mediated by cAMP accumulation.
In conclusion, the results of the present study are summarized in Fig. 11 . When IDM or ASA was used with ACh or ionomycin, the stripped mucosa was incubated in the control solution with IDM or ASA for 10 min before stimulation. Each value of PGE2 released for 10 min (g/g mucosa) was calculated from 3 different experiments. PGE2 was released from unstimulated antral mucosa in the control experiments (10 l DMSO). ACh and ionomycin increased the PGE2 release from the antral mucosa. However, IDM or ASA suppressed the PGE2 release from the unstimulated and stimulated antral mucosa. *P Ͻ 0.05 vs. control. Fig. 11 . Autocrine regulation of exocytosis in antral mucous cells during ACh stimulation.
